The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.
Tarih
2020Yazar
Aurora-Garg, Deepti
Lu, Jia
Shih, Chie-Schin
Adelberg, David
Cao, Z. Alexander
Fabrizio, David
Fuchs, Charles S.
Cristescu, Razvan
Kobie, Julie
Van Cutsem, Eric
Muro, Kei
Chung, Hyun Cheol
Olesinski, Tomasz
Vivaldi, Caterina
Ryu, Min-hee
Mandal, Mario
Di Bartolomeo, Maria
Bang, Yung-Jue
Ozguroglu, Mustafa
Shitara, Kohei
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Makale [92796]